Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease.

HemaSphere
Lukas M Braun, Robert Zeiser

Abstract

Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative therapy for patients suffering from hematological malignancies, and its therapeutic success is based on the graft-versus-leukemia (GvL) effect. Severe acute and chronic graft-versus-host disease (GvHD) are life-threatening complications after allo-HCT. To date, most of the approved treatment strategies for GvHD rely on broadly immunosuppressive regimens, which limit the beneficial GvL effect by reducing the cytotoxicity of anti-leukemia donor T-cells. Therefore, novel therapeutic strategies that rely on immunomodulatory rather than only immunosuppressive effects could help to improve patient outcomes. Treatments should suppress severe GvHD while preserving anti-leukemia immunity. New treatment strategies include the blockade of T-cell activation via inhibition of dipeptidyl peptidase 4 and cluster of differentiation 28-mediated co-stimulation, reduction of proinflammatory interleukin (IL)-2, IL-6 and tumor necrosis factor-α signaling, as well as kinase inhibition. Janus kinase (JAK)1/2 inhibition acts directly on T-cells, but also renders antigen presenting cells more tolerogenic and blocks dendritic cell-mediated T-cell activation and proli...Continue Reading

References

Feb 1, 1991·Journal of Bacteriology·P J Solenberg, R H Baltz
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M SykesD H Sachs
Feb 5, 1987·The New England Journal of Medicine·R EdelsonG Plewig
Jun 18, 2003·Trends in Immunology·Vincenzo BrontePaola Zanovello
Apr 8, 2004·Blood·Daniel CourielRichard Champlin
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Akira MaedaThomas Schwarz
Oct 26, 2005·Bone Marrow Transplantation·D T TeacheyN Bunin
May 30, 2006·Transplantation·Olle RingdénKatarina Le Blanc
May 16, 2007·The Journal of Biological Chemistry·Christian SchindlerThomas Decker
Mar 14, 2009·Lancet·James L M FerraraErnst Holler
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel R CourielAmin Alousi
Sep 17, 2010·The New England Journal of Medicine·Srdan VerstovsekAyalew Tefferi
Nov 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Isao TawaraPavan Reddy
Nov 26, 2010·Nature Medicine·Konrad WilhelmRobert Zeiser
Dec 2, 2011·The New England Journal of Medicine·John KorethRobert J Soiffer
May 23, 2013·British Journal of Haematology·Ryo HatanoChikao Morimoto
Aug 28, 2013·The Journal of Experimental Medicine·Dragana JankovicRobert Zeiser
Sep 21, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Divya T KouraLeslie S Kean
Feb 20, 2014·Frontiers in Immunology·Rosa BacchettaMaria-Grazia Roncarolo
Feb 28, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alana A Kennedy-NasserCatherine M Bollard
Apr 9, 2014·Blood·Silvia SpoerlNikolas von Bubnoff
Jun 4, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Erin GatzaSung Won Choi

❮ Previous
Next ❯

Citations

Aug 17, 2021·Frontiers in Immunology·Nicholas J HessChristian M Capitini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2021 Meta ULC. All rights reserved